Australia circles wagon around drugs as US tariffs loom
The US president has laid out plans to impose 200 per cent tariffs on drug imports in a year's time, threatening Australia's third-most significant export to America.
Mr Trump's proposal comes after lobbying by the powerful US pharmaceutical sector, which has long taken issue with Australia's drug subsidy scheme and wants the president to act so it can sell drugs to Australians for more.
His announcement could be seen as a way for the US to chip away at the Pharmaceutical Benefits Scheme in exchange for a tariff exemption or trade deal.
But Treasurer Jim Chalmers has ruled that out.
"Our Pharmaceutical Benefits Scheme is not something that we're willing to trade away or do deals on," he told ABC radio on Wednesday.
Mr Trump also revealed a 50 per cent tariff on copper imported to the US, but this poses less of a problem for Australia as the US accounts for less than one per cent of its copper exports.
By comparison, Australia sent $2.1 billion worth of medicinal and pharmaceuticals to the US in 2024, according to the Australia Bureau of Statistics.
The president's remarks are the latest in a series of new trade measures, after he unveiled an increased 25 per cent tariff on items from Japan and Korea, which are Australia's second- and third-biggest export markets.
Although Australia has been spared for now, it remains vulnerable to flow-on effects, Monash University economics lecturer Isaac Gross said.
One of Australia's main exports to Japan and South Korea is iron ore, which is used to make vehicles, many of which are sent to the US.
But if cars sale fall off in the American market, that could mean less demand for Australian iron ore, which could also impact mining giants like BHP and Rio Tinto.
"The principal way that affects the Australian economy is through a lower Australian dollar and less tax revenue," Dr Gross told AAP.
"That would affect Australians as a whole ... it would definitely hurt the government's budget line and reduce economic activity, in especially the mining states."
There could be some upside for Australian consumers as South Korean or Japanese goods that would normally have been exported to the US might be sent to Australia at a discounted price.
But Dr Chalmers maintains the escalating trade tensions around the world were a "substantial concern" and that tariffs pose a risk to global growth.
A number of countries have tried to strike trade deals with the US to get some certainty from the tariff volatility.
However, many are now growing frustrated, according to University of Sydney associate professor David Smith.
"They think that negotiations are going in one direction and then Trump makes a sudden announcement that takes it in another direction," he told AAP.
Prime Minister Anthony Albanese has faced increasing pressure to schedule a face-to-face meeting with the US president and push for a total tariff exemption.
But it is unclear if that would work.
Japanese Prime Minister Shigeru Ishiba met Mr Trump in February, but by July the US president revealed his increased tariffs on the Asian nation and appeared to skip over its leader's name, calling him "Mr Japan" in a recent interview.
"I can see why the (Australian) prime minister would be seeking a face-to-face meeting, but it doesn't have the same kind of certainty that it had in the past," Prof Smith said.
"Now we're in a situation where the US is trying to negotiate 100 trade deals at once - it's clearly beyond the capacity of American negotiators.
"Trump is getting very frustrated. Trump's blaming other countries for the slowness of the negotiations and now he's lashing out."
One of Australia's biggest exports to the United States could be slapped with triple-digit tariffs after Donald Trump vowed to expand his trade war.
The US president has laid out plans to impose 200 per cent tariffs on drug imports in a year's time, threatening Australia's third-most significant export to America.
Mr Trump's proposal comes after lobbying by the powerful US pharmaceutical sector, which has long taken issue with Australia's drug subsidy scheme and wants the president to act so it can sell drugs to Australians for more.
His announcement could be seen as a way for the US to chip away at the Pharmaceutical Benefits Scheme in exchange for a tariff exemption or trade deal.
But Treasurer Jim Chalmers has ruled that out.
"Our Pharmaceutical Benefits Scheme is not something that we're willing to trade away or do deals on," he told ABC radio on Wednesday.
Mr Trump also revealed a 50 per cent tariff on copper imported to the US, but this poses less of a problem for Australia as the US accounts for less than one per cent of its copper exports.
By comparison, Australia sent $2.1 billion worth of medicinal and pharmaceuticals to the US in 2024, according to the Australia Bureau of Statistics.
The president's remarks are the latest in a series of new trade measures, after he unveiled an increased 25 per cent tariff on items from Japan and Korea, which are Australia's second- and third-biggest export markets.
Although Australia has been spared for now, it remains vulnerable to flow-on effects, Monash University economics lecturer Isaac Gross said.
One of Australia's main exports to Japan and South Korea is iron ore, which is used to make vehicles, many of which are sent to the US.
But if cars sale fall off in the American market, that could mean less demand for Australian iron ore, which could also impact mining giants like BHP and Rio Tinto.
"The principal way that affects the Australian economy is through a lower Australian dollar and less tax revenue," Dr Gross told AAP.
"That would affect Australians as a whole ... it would definitely hurt the government's budget line and reduce economic activity, in especially the mining states."
There could be some upside for Australian consumers as South Korean or Japanese goods that would normally have been exported to the US might be sent to Australia at a discounted price.
But Dr Chalmers maintains the escalating trade tensions around the world were a "substantial concern" and that tariffs pose a risk to global growth.
A number of countries have tried to strike trade deals with the US to get some certainty from the tariff volatility.
However, many are now growing frustrated, according to University of Sydney associate professor David Smith.
"They think that negotiations are going in one direction and then Trump makes a sudden announcement that takes it in another direction," he told AAP.
Prime Minister Anthony Albanese has faced increasing pressure to schedule a face-to-face meeting with the US president and push for a total tariff exemption.
But it is unclear if that would work.
Japanese Prime Minister Shigeru Ishiba met Mr Trump in February, but by July the US president revealed his increased tariffs on the Asian nation and appeared to skip over its leader's name, calling him "Mr Japan" in a recent interview.
"I can see why the (Australian) prime minister would be seeking a face-to-face meeting, but it doesn't have the same kind of certainty that it had in the past," Prof Smith said.
"Now we're in a situation where the US is trying to negotiate 100 trade deals at once - it's clearly beyond the capacity of American negotiators.
"Trump is getting very frustrated. Trump's blaming other countries for the slowness of the negotiations and now he's lashing out."
One of Australia's biggest exports to the United States could be slapped with triple-digit tariffs after Donald Trump vowed to expand his trade war.
The US president has laid out plans to impose 200 per cent tariffs on drug imports in a year's time, threatening Australia's third-most significant export to America.
Mr Trump's proposal comes after lobbying by the powerful US pharmaceutical sector, which has long taken issue with Australia's drug subsidy scheme and wants the president to act so it can sell drugs to Australians for more.
His announcement could be seen as a way for the US to chip away at the Pharmaceutical Benefits Scheme in exchange for a tariff exemption or trade deal.
But Treasurer Jim Chalmers has ruled that out.
"Our Pharmaceutical Benefits Scheme is not something that we're willing to trade away or do deals on," he told ABC radio on Wednesday.
Mr Trump also revealed a 50 per cent tariff on copper imported to the US, but this poses less of a problem for Australia as the US accounts for less than one per cent of its copper exports.
By comparison, Australia sent $2.1 billion worth of medicinal and pharmaceuticals to the US in 2024, according to the Australia Bureau of Statistics.
The president's remarks are the latest in a series of new trade measures, after he unveiled an increased 25 per cent tariff on items from Japan and Korea, which are Australia's second- and third-biggest export markets.
Although Australia has been spared for now, it remains vulnerable to flow-on effects, Monash University economics lecturer Isaac Gross said.
One of Australia's main exports to Japan and South Korea is iron ore, which is used to make vehicles, many of which are sent to the US.
But if cars sale fall off in the American market, that could mean less demand for Australian iron ore, which could also impact mining giants like BHP and Rio Tinto.
"The principal way that affects the Australian economy is through a lower Australian dollar and less tax revenue," Dr Gross told AAP.
"That would affect Australians as a whole ... it would definitely hurt the government's budget line and reduce economic activity, in especially the mining states."
There could be some upside for Australian consumers as South Korean or Japanese goods that would normally have been exported to the US might be sent to Australia at a discounted price.
But Dr Chalmers maintains the escalating trade tensions around the world were a "substantial concern" and that tariffs pose a risk to global growth.
A number of countries have tried to strike trade deals with the US to get some certainty from the tariff volatility.
However, many are now growing frustrated, according to University of Sydney associate professor David Smith.
"They think that negotiations are going in one direction and then Trump makes a sudden announcement that takes it in another direction," he told AAP.
Prime Minister Anthony Albanese has faced increasing pressure to schedule a face-to-face meeting with the US president and push for a total tariff exemption.
But it is unclear if that would work.
Japanese Prime Minister Shigeru Ishiba met Mr Trump in February, but by July the US president revealed his increased tariffs on the Asian nation and appeared to skip over its leader's name, calling him "Mr Japan" in a recent interview.
"I can see why the (Australian) prime minister would be seeking a face-to-face meeting, but it doesn't have the same kind of certainty that it had in the past," Prof Smith said.
"Now we're in a situation where the US is trying to negotiate 100 trade deals at once - it's clearly beyond the capacity of American negotiators.
"Trump is getting very frustrated. Trump's blaming other countries for the slowness of the negotiations and now he's lashing out."
One of Australia's biggest exports to the United States could be slapped with triple-digit tariffs after Donald Trump vowed to expand his trade war.
The US president has laid out plans to impose 200 per cent tariffs on drug imports in a year's time, threatening Australia's third-most significant export to America.
Mr Trump's proposal comes after lobbying by the powerful US pharmaceutical sector, which has long taken issue with Australia's drug subsidy scheme and wants the president to act so it can sell drugs to Australians for more.
His announcement could be seen as a way for the US to chip away at the Pharmaceutical Benefits Scheme in exchange for a tariff exemption or trade deal.
But Treasurer Jim Chalmers has ruled that out.
"Our Pharmaceutical Benefits Scheme is not something that we're willing to trade away or do deals on," he told ABC radio on Wednesday.
Mr Trump also revealed a 50 per cent tariff on copper imported to the US, but this poses less of a problem for Australia as the US accounts for less than one per cent of its copper exports.
By comparison, Australia sent $2.1 billion worth of medicinal and pharmaceuticals to the US in 2024, according to the Australia Bureau of Statistics.
The president's remarks are the latest in a series of new trade measures, after he unveiled an increased 25 per cent tariff on items from Japan and Korea, which are Australia's second- and third-biggest export markets.
Although Australia has been spared for now, it remains vulnerable to flow-on effects, Monash University economics lecturer Isaac Gross said.
One of Australia's main exports to Japan and South Korea is iron ore, which is used to make vehicles, many of which are sent to the US.
But if cars sale fall off in the American market, that could mean less demand for Australian iron ore, which could also impact mining giants like BHP and Rio Tinto.
"The principal way that affects the Australian economy is through a lower Australian dollar and less tax revenue," Dr Gross told AAP.
"That would affect Australians as a whole ... it would definitely hurt the government's budget line and reduce economic activity, in especially the mining states."
There could be some upside for Australian consumers as South Korean or Japanese goods that would normally have been exported to the US might be sent to Australia at a discounted price.
But Dr Chalmers maintains the escalating trade tensions around the world were a "substantial concern" and that tariffs pose a risk to global growth.
A number of countries have tried to strike trade deals with the US to get some certainty from the tariff volatility.
However, many are now growing frustrated, according to University of Sydney associate professor David Smith.
"They think that negotiations are going in one direction and then Trump makes a sudden announcement that takes it in another direction," he told AAP.
Prime Minister Anthony Albanese has faced increasing pressure to schedule a face-to-face meeting with the US president and push for a total tariff exemption.
But it is unclear if that would work.
Japanese Prime Minister Shigeru Ishiba met Mr Trump in February, but by July the US president revealed his increased tariffs on the Asian nation and appeared to skip over its leader's name, calling him "Mr Japan" in a recent interview.
"I can see why the (Australian) prime minister would be seeking a face-to-face meeting, but it doesn't have the same kind of certainty that it had in the past," Prof Smith said.
"Now we're in a situation where the US is trying to negotiate 100 trade deals at once - it's clearly beyond the capacity of American negotiators.
"Trump is getting very frustrated. Trump's blaming other countries for the slowness of the negotiations and now he's lashing out."
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
The Age
7 minutes ago
- The Age
WA news LIVE: Man pulled from burning house in Mirrabooka
Latest posts Latest posts 9.41am Police pull man from burning house in Mirrabooka A man in his 60s has been pulled from his burning house in Mirrabooka after emergency services were called to the blaze in the early hours of Thursday. Police and firefighters rushed to the scene at Otago Mews about 1am this morning, with several police being the first to arrive. They soon learned a person was still inside the home, and smashed a window to get inside. 'The officers were able to find the man inside the burning home and extricate him from the premises,' a WA Police spokeswoman said. The man was taken to Fiona Stanley Hospital for treatment of significant smoke inhalation, among other injuries. The officers who saved him also suffered smoke inhalation, and one was also taken to hospital for treatment, the spokeswoman said. Firefighters managed to extinguish the blaze, but the home was badly damaged. 9.41am Across Australia and around the world Here's what's making headlines elsewhere today: White House special envoy Steve Witkoff met Russian President Vladimir Putin in Moscow hours ago, in an almost three-hour meeting that canvassed Donald Trump's threat to intensify sanctions and tariffs on Russia if an urgent move towards a ceasefire with Ukraine wasn't achieved. Trump described the meeting as 'highly productive', noting that 'great progress was made' towards ending Russia's war in Ukraine. A proposal that would see all Australians receive $3300 a year in exchange for accepting a higher and broader GST has been proposed ahead of this month's economic reform roundtable. The plan would lift the GST to 15 per cent and extend the tax on food, education, health and childcare services, and water and sewerage, with proponents arguing it would boost the budget by $28 billion a year and drive up national living standards. , days after the Indian government warned against new trade penalties. The move is designed to penalise India for its purchasing of Russian oil, as Trump continues work to negotiate an end to Russia's war in Ukraine.
Sydney Morning Herald
7 minutes ago
- Sydney Morning Herald
WA news LIVE: Man pulled from burning house in Mirrabooka
Latest posts Latest posts 9.41am Police pull man from burning house in Mirrabooka A man in his 60s has been pulled from his burning house in Mirrabooka after emergency services were called to the blaze in the early hours of Thursday. Police and firefighters rushed to the scene at Otago Mews about 1am this morning, with several police being the first to arrive. They soon learned a person was still inside the home, and smashed a window to get inside. 'The officers were able to find the man inside the burning home and extricate him from the premises,' a WA Police spokeswoman said. The man was taken to Fiona Stanley Hospital for treatment of significant smoke inhalation, among other injuries. The officers who saved him also suffered smoke inhalation, and one was also taken to hospital for treatment, the spokeswoman said. Firefighters managed to extinguish the blaze, but the home was badly damaged. 9.41am Across Australia and around the world Here's what's making headlines elsewhere today: White House special envoy Steve Witkoff met Russian President Vladimir Putin in Moscow hours ago, in an almost three-hour meeting that canvassed Donald Trump's threat to intensify sanctions and tariffs on Russia if an urgent move towards a ceasefire with Ukraine wasn't achieved. Trump described the meeting as 'highly productive', noting that 'great progress was made' towards ending Russia's war in Ukraine. A proposal that would see all Australians receive $3300 a year in exchange for accepting a higher and broader GST has been proposed ahead of this month's economic reform roundtable. The plan would lift the GST to 15 per cent and extend the tax on food, education, health and childcare services, and water and sewerage, with proponents arguing it would boost the budget by $28 billion a year and drive up national living standards. , days after the Indian government warned against new trade penalties. The move is designed to penalise India for its purchasing of Russian oil, as Trump continues work to negotiate an end to Russia's war in Ukraine.
Perth Now
7 minutes ago
- Perth Now
Big problem with essential Aussie scheme
Health Minister Mark Butler says he is looking at recommendations to speed up medicine approvals amid pressure from lobbyists both within Australia and in the US. Medicines Australia has repeatedly highlighted that Australia lags behind comparable countries in listing new medicines on the Pharmaceutical Benefits Scheme (PBS) – a list of federally subsidised medicines. It takes an average of 466 days from when the Therapeutic Goods Administration approves a medicine to when it becomes affordable on the PBS, according to the peak body. This is much longer than in the UK and Canada, for example. The lengthy timeline has also angered the Pharmaceutical Research and Manufacturers of America (PhRMA), which has framed the PBS as a 'non-tariff trade barrier' that harms American companies in representations to the Trump administration. Lengthy PBS listing times is among PhRMA's core criticisms. Mr Butler said on Thursday he would look at Medicines Australia's recommendations to make the 'approvals system quicker'. Powerful pharmaceutical lobbyists in the US have accused Australia of 'freeloading' on the high prices paid by American consumers. Martin Ollman / NewsWire Credit: News Corp Australia 'We're getting an enormous number of new medicining coming on to the market,' he told the ABC. 'We're living through a turbocharged period of discovery bringing more and more new medicine, so making sure that we can assess them and approve them very quickly to get them into patients as quickly as possible is something I've said is a real priority for us this term.' Because the PBS compels drugmakers to negotiate prices with the federal government, PhRMA has accused Australia of 'freeloading' on US-funded research and development. Meanwhile, American consumers pick up the bill, according to the lobby group. 'The medicines industry, understandably, given their interest, want to make prices higher as well, so there will be a bit of a debate about how we do that,' Mr Butler said. 'But I'm very much on the page of getting medicines more quickly into our system, our PBS system. 'It's a terrific system and we're trying to make medicines cheaper at the same time for Australians.' PhRMA has explicitly urged the Trump administration to 'leverage ongoing trade negotiations' to influence Australia's PBS policies. Mr Butler has echoed Anthony Albanese and fellow senior government ministers in ruling out any 'compromise' on the system as part of tariff talks. For the moment, Donald Trump's concern with the sector appears to be largely focused on bringing down prices in the US rather than punishing allies for having cheaper medicines. A RAND Corporation report found that Americans pay nearly four times more than Australians for medicines and about three times more than the average in other developed economies. The answer, according to the US President, is to make pharmaceuticals in the US. In a warning shot to firms, Mr Trump this week threatened to slap tariffs of up to 250 per cent on foreign-made products. With Australian pharma exports to the US worth more than $2bn in 2024, it would hit producers Down Under hard. Exports are mostly blood products and vaccines but also include packaged medicines and miscellaneous products, such as bandages. 'We'll be putting (an) initially small tariff on pharmaceuticals,' Mr Trump told US business news channel CNBC. 'In one year, 1½ years maximum, it's going to go to 150 per cent and then it's going to go to 250 per cent because we want pharmaceuticals made in our country.' He did not say what the initial rate would be, but earlier in the year he said duties on the sector would start from 25 per cent. Mr Trump last week wrote to 17 major pharmaceutical companies demanding they lower their prices for American consumers and bring them in line with prices overseas.
